Market Overview:
The India pharmaceutical market size reached US$ 42.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 88.6 Billion by 2027, exhibiting a growth rate (CAGR) of 13.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A pharmaceutical refers to a drug used for treating different forms of illness, such as flu, sexually transmitted diseases (STDs), cardiovascular disease, diabetes, Parkinson’s disease, and cancer. It helps improve lives of individuals and manage symptoms efficiently as compared to traditional methods. At present, there is a rise in the sales of pharmaceuticals across India due to the escalating demand for pain management and acute therapies, such as gastro and respiratory, among individuals.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information on the regional analysis of this market, Request Sample
India Pharmaceutical Market Trends:
The growing demand for pharmaceuticals during the coronavirus disease (COVID-19) pandemic in India to provide adequate medicines to patients represent one of the key factors driving the market. Moreover, the Government of India is extensively investing in research and development (R&D) activities that support rapid drug discovery for improving health outcomes. This, along with the increasing expertise of key market players in specialty pharmaceuticals such as novel biologics and biosimilars, complex generics, and preventive medication, is positively influencing the market. In addition, the rising utilization of intelligent automation in the pharmaceutical industry to diagnose and manage diseases is propelling the growth of the market. Besides this, the development of the single-window system to streamline the drug development process and facilitate fast approvals of commercially viable projects is catalyzing the demand for pharmaceuticals in the country. Additionally, increasing investments in long-term and high-risk projects by various funding avenues in India is offering lucrative growth opportunities to industry investors. Furthermore, inflating income levels and improving medical infrastructure is propelling the sales of pharmaceuticals. Some of the other factors stimulating the growth of the market in the country are lower manufacturing costs, a highly skilled workforce, technological advancements, and enhanced marketing and distribution system.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the India pharmaceutical market report, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on type and nature.
Breakup by Type:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
To get more information on the regional analysis of this market, Request Sample
- Pharmaceutical Drugs
- Cardiovascular Drugs
- Dermatology Drugs
- Gastrointestinal Drugs
- Genito-Urinary Drugs
- Hematology Drugs
- Anti-Infective Drugs
- Metabolic Disorder Drugs
- Musculoskeletal Disorder Drugs
- Central Nervous System Drugs
- Oncology Drugs
- Ophthalmology Drugs
- Respiratory Diseases Drugs
- Biologics
- Monoclonal Antibodies (MAbS)
- Therapeutic Proteins
- Vaccines
Breakup by Nature:
Breakup by Region:
- North India
- West and Central India
- South India
- East India
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Type, Nature, Region |
| Region Covered |
North India, West and Central India, South India, East India |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the India pharmaceutical market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the India pharmaceutical market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the nature?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the India pharmaceutical market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 India Pharmaceutical Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Pharmaceutical Drugs
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Cardiovascular Drugs
6.1.2.2 Dermatology Drugs
6.1.2.3 Gastrointestinal Drugs
6.1.2.4 Genito-Urinary Drugs
6.1.2.5 Hematology Drugs
6.1.2.6 Anti-Infective Drugs
6.1.2.7 Metabolic Disorder Drugs
6.1.2.8 Musculoskeletal Disorder Drugs
6.1.2.9 Central Nervous System Drugs
6.1.2.10 Oncology Drugs
6.1.2.11 Ophthalmology Drugs
6.1.2.12 Respiratory Diseases Drugs
6.1.3 Market Forecast
6.2 Biologics
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Monoclonal Antibodies (MAbS)
6.2.2.2 Therapeutic Proteins
6.2.2.3 Vaccines
6.2.3 Market Forecast
7 Market Breakup by Nature
7.1 Organic
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Conventional
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Region
8.1 North India
8.1.1 Market Trends
8.1.2 Market Breakup by State
8.1.3 Market Forecast
8.2 West and Central India
8.2.1 Market Trends
8.2.2 Market Breakup by State
8.2.3 Market Forecast
8.3 South India
8.3.1 Market Trends
8.3.2 Market Breakup by State
8.3.3 Market Forecast
8.4 East India
8.4.1 Market Trends
8.4.2 Market Breakup by State
8.4.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Policy and Regulatory Landscape
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
List of Figures
Figure 1: India: Pharmaceutical Market: Major Drivers and Challenges
Figure 2: India: Pharmaceutical Market: Sales Value (in Billion US$), 2016-2021
Figure 3: India: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: India: Pharmaceutical Market: Breakup by Type (in %), 2021
Figure 5: India: Pharmaceutical Market: Breakup by Nature (in %), 2021
Figure 6: India: Pharmaceutical Market: Breakup by Region (in %), 2021
Figure 7: India: Pharmaceutical (Pharmaceutical Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: India: Pharmaceutical (Pharmaceutical Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: India: Pharmaceutical (Biologics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: India: Pharmaceutical (Biologics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: India: Pharmaceutical (Organic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: India: Pharmaceutical (Organic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: India: Pharmaceutical (Conventional) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: India: Pharmaceutical (Conventional) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: North India: Pharmaceutical Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: North India: Pharmaceutical Market: Breakup by State (in %), 2021
Figure 17: North India: Pharmaceutical Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: West and Central India: Pharmaceutical Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: West and Central India: Pharmaceutical Market: Breakup by State (in %), 2021
Figure 20: West and Central India: Pharmaceutical Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: South India: Pharmaceutical Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: South India: Pharmaceutical Market: Breakup by State (in %), 2021
Figure 23: South India: Pharmaceutical Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: East India: Pharmaceutical Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: East India: Pharmaceutical Market: Breakup by State (in %), 2021
Figure 26: East India: Pharmaceutical Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: India: Pharmaceutical Industry: SWOT Analysis
Figure 28: India: Pharmaceutical Industry: Value Chain Analysis
Figure 29: India: Pharmaceutical Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: India: Pharmaceutical Market: Key Industry Highlights, 2021 and 2027
Table 2: India: Pharmaceutical Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: India: Pharmaceutical Market Forecast: Breakup by Nature (in Million US$), 2022-2027
Table 4: India: Pharmaceutical Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: India: Pharmaceutical Market: Competitive Structure
Table 6: India: Pharmaceutical Market: Key Players